Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 7540 | 316.01 |
09:34 ET | 2400 | 316.01 |
09:36 ET | 1800 | 316.38 |
09:38 ET | 1805 | 316.38 |
09:39 ET | 1034 | 316.535 |
09:41 ET | 300 | 316.535 |
09:43 ET | 6908 | 316.395 |
09:45 ET | 100 | 316.165 |
09:48 ET | 661 | 316.25 |
09:50 ET | 200 | 316.635 |
09:52 ET | 300 | 317.325 |
09:54 ET | 200 | 317.095 |
09:56 ET | 200 | 316.94 |
09:57 ET | 1500 | 317.2 |
09:59 ET | 400 | 317.55 |
10:01 ET | 400 | 317.31 |
10:03 ET | 1449 | 318.42 |
10:06 ET | 100 | 318.475 |
10:12 ET | 664 | 318.635 |
10:14 ET | 200 | 318.67 |
10:15 ET | 600 | 319.06 |
10:17 ET | 310 | 318.725 |
10:19 ET | 600 | 318.8 |
10:21 ET | 100 | 318.865 |
10:24 ET | 5143 | 318.49 |
10:26 ET | 300 | 318.48 |
10:28 ET | 300 | 318.21 |
10:30 ET | 200 | 317.93 |
10:32 ET | 200 | 318.005 |
10:33 ET | 653 | 317.68 |
10:35 ET | 1650 | 318.365 |
10:37 ET | 100 | 318.395 |
10:39 ET | 800 | 318.6 |
10:42 ET | 400 | 318.475 |
10:46 ET | 1578 | 318.58 |
10:48 ET | 486 | 318.66 |
10:50 ET | 1840 | 317.84 |
10:51 ET | 300 | 317.8 |
10:53 ET | 2700 | 318.13 |
10:55 ET | 274 | 318.175 |
10:57 ET | 200 | 318.205 |
11:00 ET | 100 | 318.205 |
11:02 ET | 700 | 318.195 |
11:04 ET | 800 | 317.94 |
11:06 ET | 400 | 318.2 |
11:08 ET | 200 | 318.195 |
11:09 ET | 500 | 318.19 |
11:11 ET | 2840 | 317.92 |
11:13 ET | 290 | 317.675 |
11:15 ET | 100 | 317.6 |
11:20 ET | 100 | 317.9 |
11:22 ET | 5500 | 317.55 |
11:24 ET | 356 | 317.6 |
11:26 ET | 2454 | 318.16 |
11:27 ET | 1100 | 318.015 |
11:31 ET | 100 | 317.79 |
11:33 ET | 500 | 317.65 |
11:36 ET | 681 | 317.58 |
11:38 ET | 100 | 317.65 |
11:40 ET | 100 | 317.6 |
11:42 ET | 200 | 317.27 |
11:44 ET | 200 | 317.5 |
11:45 ET | 1334 | 317.835 |
11:47 ET | 481 | 318.14 |
11:49 ET | 400 | 318.215 |
11:51 ET | 300 | 318.14 |
11:56 ET | 400 | 319.105 |
11:58 ET | 700 | 319.35 |
12:00 ET | 890 | 319.06 |
12:02 ET | 510 | 319.36 |
12:03 ET | 100 | 319.355 |
12:09 ET | 1098 | 320.07 |
12:16 ET | 651 | 320.295 |
12:18 ET | 100 | 320.57 |
12:20 ET | 900 | 320.365 |
12:21 ET | 100 | 320.355 |
12:25 ET | 400 | 320.35 |
12:27 ET | 600 | 320.83 |
12:30 ET | 100 | 320.975 |
12:32 ET | 1666 | 320.865 |
12:34 ET | 306 | 320.825 |
12:36 ET | 300 | 320.82 |
12:38 ET | 1933 | 320.59 |
12:39 ET | 400 | 320.3526 |
12:41 ET | 2474 | 321 |
12:43 ET | 700 | 320.835 |
12:48 ET | 900 | 321.02 |
12:50 ET | 3440 | 320.505 |
12:52 ET | 270 | 320.97 |
12:54 ET | 600 | 320.89 |
12:56 ET | 100 | 320.86 |
12:57 ET | 100 | 321.07 |
12:59 ET | 100 | 320.86 |
01:01 ET | 511 | 320.86 |
01:03 ET | 700 | 320.59 |
01:06 ET | 2983 | 319.72 |
01:08 ET | 100 | 319.735 |
01:10 ET | 200 | 319.235 |
01:12 ET | 1200 | 319.235 |
01:14 ET | 500 | 318.95 |
01:15 ET | 400 | 319.1 |
01:17 ET | 580 | 319.25 |
01:19 ET | 479 | 318.905 |
01:21 ET | 600 | 318.27 |
01:26 ET | 200 | 318.49 |
01:28 ET | 100 | 318.07 |
01:30 ET | 100 | 318.42 |
01:32 ET | 1116 | 318.83 |
01:33 ET | 100 | 318.765 |
01:35 ET | 1850 | 319.3 |
01:37 ET | 400 | 319.255 |
01:39 ET | 400 | 318.93 |
01:42 ET | 100 | 318.915 |
01:44 ET | 100 | 318.91 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 14.2B | 15.1x | +8.22% |
Biomarin Pharmaceutical Inc | 16.1B | 80.3x | --- |
Neurocrine Biosciences Inc | 13.6B | 37.3x | +62.04% |
Beigene Ltd | 17.1B | -19.4x | --- |
Medpace Holdings Inc | 12.6B | 41.5x | +35.10% |
Qiagen NV | 9.1B | 27.0x | +12.66% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.2B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.56 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 15.1x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | 12.8x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.